Sinus Relief
Active substance: ASAFETIDA, ECHINACEA ANGUSTIFOLIA, CALCIUM SULFIDE, POTASSIUM DICHROMATE, LUFFA OPERCULATA WHOLE, SILICON DIOXIDE, SINUSITISINUM
PELLET · ASAFETIDA 8 [hp_X]/4g, ECHINACEA ANGUSTIFOLIA 12 [hp_X]/4g, CALCIUM SULFIDE 8 [hp_X]/4g, POTASSIUM DICHROMATE 18 [hp_X]/4g, LUFFA OPERCULATA WHOLE 9 [hp_C]/4g, SILICON DIOXIDE 10 [hp_X]/4g, SINUSITISINUM 18 [hp_X]/4g
United StatesActive
Marketing holder: Homeocare Laboratories
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- ASAFETIDA · 8 [hp_X]/4g
- ECHINACEA ANGUSTIFOLIA · 12 [hp_X]/4g
- CALCIUM SULFIDE · 8 [hp_X]/4g
- POTASSIUM DICHROMATE · 18 [hp_X]/4g
- LUFFA OPERCULATA WHOLE · 9 [hp_C]/4g
- SILICON DIOXIDE · 10 [hp_X]/4g
- SINUSITISINUM · 18 [hp_X]/4g
Registration
- Registration number
- 61727-335
- Registration status
- Active
- Dispensing
- Over the counter
- Route
- SUBLINGUAL
Sources
- product · openFDA NDC · 61727-335 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 61727-335 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 61727-335 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 61727-335 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 61727-335 · Verified 2026-10-09 · open in source
- ingredients.3 · openFDA NDC · 61727-335 · Verified 2026-10-09 · open in source
- ingredients.4 · openFDA NDC · 61727-335 · Verified 2026-10-09 · open in source
- ingredients.5 · openFDA NDC · 61727-335 · Verified 2026-10-09 · open in source
- ingredients.6 · openFDA NDC · 61727-335 · Verified 2026-10-09 · open in source